Scholarly Index
Vicente Valero
The University of Texas MD Anderson Cancer Center; 47,974 total citations; 756 total publications; best world rank #7
The University of Texas MD Anderson Cancer Center
47,974Total citations
756Total publications
119H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 24 | US 14 | 99.89 |
| Breast Cancer Treatment Studies | Lifetime | 41 | US 23 | 99.83 |
| Chemotherapy-related skin toxicity | Lifetime | 7 | US 4 | 99.56 |
| HER2/EGFR in Cancer Research | Lifetime | 49 | US 27 | 99.72 |
| Advanced Breast Cancer Therapies | Lifetime | 72 | US 36 | 99.36 |
| Breast Lesions and Carcinomas | Lifetime | 105 | US 60 | 99.04 |
| Neutropenia and Cancer Infections | Lifetime | 149 | US 74 | 98.42 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 128 | US 74 | 96.96 |
| Colorectal Cancer Treatments and Studies | Lifetime | 854 | US 327 | 97.60 |
| Cancer Cells and Metastasis | Lifetime | 913 | US 392 | 96.56 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 494 | US 159 | 74.94 |
| Cancer Treatment and Pharmacology | 2021-2025 | 285 | US 100 | 94.36 |
| Breast Cancer Treatment Studies | 2021-2025 | 448 | US 148 | 95.30 |
| HER2/EGFR in Cancer Research | 2021-2025 | 322 | US 115 | 94.81 |
| Advanced Breast Cancer Therapies | 2021-2025 | 764 | US 264 | 86.20 |
| Breast Lesions and Carcinomas | 2021-2025 | 684 | US 199 | 78.05 |